Value to direct investor
-
Upload
scott-jordan -
Category
Documents
-
view
29 -
download
1
Transcript of Value to direct investor
Diabetic Nephropathy
Diabetic Retinopathy
Hypercholesterolemia
Oral Mucositis
Gout
Acute Lymphocytic Leukemia
Bone Metastasis
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Lymphocytic Leukemia
Endometrial Cancer
Ewing Sarcoma
Gastric Cancer
Gastrointestinal Stromal Tumors
Head And Neck Cancer
Hodgkin Lymphoma
Kidney Cancer
Liver Cancer
Malignant Mesothelioma
Medullary Thyroid Cancer
Melanoma
Multiple Myeloma
Non-Hodgkin Lymphoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Thyroid Cancer
Age Related Macular Degeneration
Keratoconjunctivitis sicca (Dry Eye)
Retinal Vein Occlusion
Acute Respiratory Distress
Syndrome
Sepsis
Staphylococcal Infections
Acute Coronary Syndrome
Angina Pectoris
Atrial Fibrillation
Coronary Artery Disease (CAD)
Critical Limb Ischemia
Hypertension
Pulmonary Arterial Hypertension
Acute Pain
Anxiety Disorders
Chronic Pain
Dementia
Diabetic Neuropathy
Obsessive-Compulsive Disorder
Osteoarthritis Pain
Parkinson's Disease
Post-Traumatic Stress Disorder
Restless Legs Syndrome
Schizophrenia
Traumatic Brain Injury
Liver Cirrhosis
Childhood Enuresis
Growth Hormone Disorders
Hyperparathyroidism
Hyperthyroidism
Guillain-Barre Syndrome
Cytomegalovirus
Fungal Infections
Gram-Negative Bacterial Infections
H1N1 Infection
Herpes Zoster
HIV-1 Infection
Human Papillomavirus Infections
Staphylococcus Aureus (MRSA)
Cardiovascular Devices
Prosthetic Heart Valve
Peripheral Vascular Devices
Cardiovascular Monitoring & Diagnostic Devices
Cardiovascular Surgery
Cardiac Rhythm Management
Cardiovascular Prosthetic Devices
Interventional Cardiology
Cardiac Assist Devices
Wound Care Management
Hospital Supplies
Syringes and Needles
Disposable Hospital & Surgical Supplies
Drug Delivery Devices
Inhalation Systems
Needle Free Injections
Infusion Systems
Diabetes Care Devices
Insulin Delivery & Glucose Monitoring
Ophthalmic Devices
Cataract Surgery Devices
Ophthalmic Diagnostic Equipment
Refractive Surgery Devices
ENT Devices
Hearing Implants
Diagnostic Devices
Electrosurgical Devices
Dental Equipment & Accessories
Diagnostic Imaging & MRI Systems
C/T Systems & Mammography Equipment
X-Ray & Ultrasound Systems
Nuclear Imaging Equipment
Contrast Media Injectors
Bone Densitometry
Anesthesia and Respiratory Devices
Anesthesia Machines & Disposables
Respiratory Devices & Disposables
Sleep Apnea Diagnostic Systems
Healthcare IT
Medical Imaging Information Systems
Nephrology and Urology Devices
Renal Dialysis Equipment
Orthopedic Devices
Orthobiologics & Arthroscopy
Joint Reconstruction
Trauma Fixation
Orthopedic Prosthetics
Cranium Maxillofacial Fixation (CMF)
Spinal Surgery
Endoscopy Devices & instruments
Rigid & Flexible Endoscope
In Vitro Diagnostics
Genetic Testing
Clinical Chemistry
Hematology
Immuno Chemistry
Infectious Immunology
Histology And Cytology
Patient Monitoring
Multiparameter Patient Monitoring
Micro-Electromechanical Systems
Non-invasive Blood Pressure Monitors
Neurology Devices
Neurostimulation Devices
Interventional Neurology
CSF Management
Neurosurgical Products
Radiosurgery
Value to the
Direct Investor
Healthcare’s Investment Marketplace
Dis
cov
ery
Dev
elo
p -
men
t I
N
D Ph
ase
I
Ph
ase
II
Ph
ase
III N
D
A Ap
pro
va
l
La
un
ch
Gro
wth
Ma
ture
Healthcare Development & Financing Cycle
IPO / Public MarketsVenture CapitalAngels / Founders Private Equity / M&A
SE
ED
EX
IT
… E M E R G I N G G R O W T H C O M PA N I E S
… ‘ L E A D ’ I N V E S T O R S
… D I R E C T I N V E S T O R S
… S T R AT E G I C PA R T N E R S & B U Y E R S
T R A N S F O R M I N G H E A LT H C A R E C A P I TA L M A R K E T S
on behalf of…
Healthcare’s Investment Marketplace
Traditional Alternative Investment Structures
Limited Partners, Family Office,
Endowments, Foreign Trusts, Private Banks,
Sovereign Wealth
Portfolio
Company
#1
Portfolio
Company
#2
Venture
CapitalPrivate
Equity
Growth
EquityHedge
Funds
Lack of ControlNo Flexibility 2% / 20%10-year Fund
Cycles
7-year
“Hold” Periods
Lower Returns /
IRRHigh Fees
Minimal
Transparency
Healthcare’s Investment Bank
HealthiosXchange for Direct Investors
HIGHER RETURNS & IRR
RULES-BASED
INVESTMENT STRATEGY
TOTAL CONTROL
12,000 Investors
Across (10)
Asset Classes
in (37) Countries &
2,000 Strategics in
(46) Market sectors
“Seed-to-Exit”
Direct/Diversified
Investment
NO
Adverse
Selection
Messaging
&
Notifications
Ratings &
Reviews
Rules-Based
Deal Flow
Prediction &
Sentiment Data
Proprietary
Events
(6,000)+
Growth
Companies
NO Fee
NO Carry
Shorter “Exit”
Horizons
Real-Time
Valuations &
Research
Less
Correlation
Reporting &
Communications
Zero
Un-Invested
Capital
Healthcare’s Investment Marketplace
HealthiosXchange: Higher Returns / IRR
Direct investment in the most promising healthcare companies.
Limited Partners, Family Office, Endowments,
Foreign Trusts, Private Banks, Sovereign Wealth
Portfolio
Company
#1
Portfolio
Company
#2
NO FEE… NO CARRY
SHORTENED HOLD
PERIODS
GREATER LIQUIDITY
Venture
Capital
Private
Equity
Growth
Equity
Hedge
Funds
Healthcare’s Investment Marketplace
HealthiosXchange: Rules-Based Investing
Rules-based, direct investing in the most promising healthcare companies.
Limited Partners, Family Office, Endowments,
Foreign Trusts, Private Banks, Sovereign Wealth
Portfolio
Company
#1
Portfolio
Company
#2
1. INSTITUTIONAL
LEADERSHIP
2. STRATEGIC
VALIDATION
3. ESTABLISHED
“EXIT”
PATHWAY
Venture
Capital
Private
Equity
Growth
Equity
Hedge
Funds
Healthcare’s Investment Marketplace
HealthiosXchange: Total Control
Direct investment in the most promising healthcare companies.
Limited Partners, Family Office, Endowments,
Foreign Trusts, Private Banks, Sovereign Wealth
Portfolio
Company
#1
Portfolio
Company
#2
Total Transparency
Direct Access to Management
Influence over Valuation &
Investment Structure
100% Discretion, Flexibility
No Adverse Selection
Ultimate Diversification
Exclusive Deal Diligence
360-Degree Communication
Proprietary Event Calendar
Roadshows, “One-on-One’s”,
Conferences
Venture
Capital
Private
Equity
Growth
Equity
Hedge
Funds
Healthcare’s Investment Bank
HealthiosXchange for Direct Investors
HIGHER RETURNS & IRR
RULES-BASED
INVESTMENT STRATEGY
TOTAL CONTROL
12,000 Investors
Across (10)
Asset Classes
in (37) Countries &
2,000 Strategics in
(46) Market sectors
“Seed-to-Exit”
Direct/Diversified
Investment
NO
Adverse
Selection
Messaging
&
Notifications
Ratings &
Reviews
Rules-Based
Deal Flow
Prediction &
Sentiment Data
Proprietary
Events
(6,000)+
Growth
Companies
NO Fee
NO Carry
Shorter “Exit”
Horizons
Real-Time
Valuations &
Research
Less
Correlation
Reporting &
Communications
Zero
Un-Invested
Capital